Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Navigated Alpha Frequency Transcranial Magnetic Stimulation (αTMS) in Treatment-resistant Schizophrenia

NCT01941251 is registered in ClinicalTrials.gov with Niuvanniemi Hospital as lead sponsor.

NCT NCT01941251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01941251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Navigated Alpha Frequency Transcranial Magnetic Stimulation (αTMS) in Treatment-resistant Schizophrenia
Lead sponsor
Niuvanniemi Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 21, 2013
Completion date
December 31, 2027
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia